Monitor for any future conversion to a 13D filing, which would signal activist intent. The passive nature of this stake suggests no near-term governance changes.
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Montanova Capital, LLC filed an amended Schedule 13G disclosing a 8.9% passive stake in Faeth Therapeutics as of September 30, 2026. The filing is an initial 13G/A from this filer; no prior Montanova 13G is in the cross-filing context, so this is a new disclosure of a 2,310,703-share position. A passive holder crossing 5% is neutral by default.
Key Financial Metrics
Key Facts
- Montanova Capital, LLC reports beneficial ownership of 2,310,703 shares of Faeth Therapeutics common stock, representing 8.9% of shares outstanding.
- Averill Master Fund, Ltd., an advisory client of Montanova, directly holds 1,969,872 shares (7.6%).
- Aaron Cowen is the control person of Montanova Capital, LLC.
- The filing is an initial Schedule 13G/A from Montanova; no prior Montanova 13G was found in the cross-filing context.
- The filer certifies the securities were not acquired to change or influence control of the issuer.
Financial Impact
8.9% passive stake valued at approximately $30.7M based on $345M market cap.
Risk Factors
- Passive 13G filer could later convert to 13D and become activist.
- No stated intention to increase or decrease position.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000919574-26-007764 |
| Document: p15120128_ex-b.htm | 0000919574-26-007764 |
| Document: 0000919574-26-007764-index-headers.html | 0000919574-26-007764 |
| Document: 0000919574-26-007764-index.html | 0000919574-26-007764 |
| Document: 0000919574-26-007764.txt | 0000919574-26-007764 |
Track record
12 reports on FTH
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +35.00% at T+60 after the Aug 11, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry price pending
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $10.03 Now $9.28 −7.48% settles Nov 17
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $12.68 to $12.92 Now $9.28 −26.81% ▲ +1.89% +2.26% vs SPY
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $12.68 to $12.92 Now $9.28 −26.81% ▲ +1.89% +2.26% vs SPY
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $19.65 to $19.99 Now $9.28 −52.77% ▲ +1.73% +0.08% vs SPY
- Oct 27, 202620d ago 3 Neutral 2/10 Entry $19.20 to $18.75 Now $9.28 −51.67% ▼ −2.34% −1.96% vs SPY
- Oct 27, 202620d ago 8-K Neutral 2/10 Entry $19.11 to $19.20 Now $9.28 −51.44% ▲ +0.47% +0.13% vs SPY
- Sep 15, 20268w ago 3 Neutral 2/10 Entry $34.24 to $35.13 Now $9.28 −72.90% ▲ +2.60% +1.47% vs SPY
- Aug 11, 202613w ago 144 Bearish 5/10 Entry $30.00 to $29.38 Now $9.28 +69.07% ▲ +2.07% +2.32% vs SPY
- Aug 4, 202614w ago 8-K Neutral 3/10 Entry $25.50 to $24.59 Now $9.28 −63.61% ▼ −3.57% −3.37% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers